Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Chemotherapy-induced Menopause by Temporary Ovarian Suppression With Triptorelin Vs. Control in Young Breast Cancer Patients. A Randomized Phase III Multicenter Study [PROMISE]

NCT00311636 is registered in ClinicalTrials.gov with Gruppo Italiano Mammella (GIM) as lead sponsor.

NCT NCT00311636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00311636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Chemotherapy-induced Menopause by Temporary Ovarian Suppression With Triptorelin Vs. Control in Young Breast Cancer Patients. A Randomized Phase III Multicenter Study [PROMISE]
Lead sponsor
Gruppo Italiano Mammella (GIM)
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2003
Completion date
April 30, 2008
Enrollment
280 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer